# Gen Digital Inc.: financial statements, quarterly

GEN · Nasdaq · CIK 849399 · [Technology](/sectors/technology.md) · fiscal year ends Mar 28

Pages: [Overview](/companies/gen.md) · [Financials](/companies/gen/financials.md) · [Filings](/companies/gen/filings.md) · [Insiders](/companies/gen/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gen/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-12-29) | Q4 FY2024 (2024-03-29) | Q1 FY2025 (2024-06-28) | Q2 FY2025 (2024-09-27) | Q3 FY2025 (2024-12-27) | Q4 FY2025 (2025-03-28) | Q1 FY2026 (2025-07-04) | Q2 FY2026 (2025-10-03) | Q3 FY2026 (2026-01-02) | Q4 FY2026 (2026-04-03) | Q1 FY2027 (2026-07-03) | Q2 FY2027 (2026-10-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [948](/filings/0000849399-25-000006.md) | [964 d](/filings/0000849399-26-000017.md) | [965](/filings/0000849399-25-000059.md) | [974](/filings/0000849399-25-000092.md) | [986](/filings/0000849399-26-000004.md) | [1,010 d](/filings/0000849399-26-000017.md) | [1,257](/filings/0000849399-26-000031.md) | [1,220](/filings/0000849399-26-000083.md) | [1,240](/filings/0000849399-26-000004.md) | [1,283 d](/filings/0000849399-26-000017.md) | [1,336](/filings/0000849399-26-000031.md) | [1,369](/filings/0000849399-26-000083.md) |
| Cost of revenue | $m | [182](/filings/0000849399-25-000006.md) | [190 d](/filings/0000849399-26-000017.md) | [190](/filings/0000849399-25-000059.md) | [194](/filings/0000849399-25-000092.md) | [193](/filings/0000849399-26-000004.md) | [199 d](/filings/0000849399-26-000017.md) | [267](/filings/0000849399-26-000031.md) | [266](/filings/0000849399-26-000083.md) | [268](/filings/0000849399-26-000004.md) | [276 d](/filings/0000849399-26-000017.md) | [307](/filings/0000849399-26-000031.md) | [330](/filings/0000849399-26-000083.md) |
| Gross profit | $m | [766](/filings/0000849399-25-000006.md) | [774 d](/filings/0000849399-26-000017.md) | [775](/filings/0000849399-25-000059.md) | [780](/filings/0000849399-25-000092.md) | [793](/filings/0000849399-26-000004.md) | [811 d](/filings/0000849399-26-000017.md) | [990](/filings/0000849399-26-000031.md) | [954](/filings/0000849399-26-000083.md) | [972](/filings/0000849399-26-000004.md) | [1,007 d](/filings/0000849399-26-000017.md) | [1,029](/filings/0000849399-26-000031.md) | [1,039](/filings/0000849399-26-000083.md) |
| Research and development | $m | [77.0](/filings/0000849399-25-000006.md) | [80.0 d](/filings/0000849399-26-000017.md) | [81.0](/filings/0000849399-25-000059.md) | [83.0](/filings/0000849399-25-000092.md) | [84.0](/filings/0000849399-26-000004.md) | [81.0 d](/filings/0000849399-26-000017.md) | [109](/filings/0000849399-26-000031.md) | [100](/filings/0000849399-26-000083.md) | [96.0](/filings/0000849399-26-000004.md) | [104 d](/filings/0000849399-26-000017.md) | [118](/filings/0000849399-26-000031.md) | [112](/filings/0000849399-26-000083.md) |
| Operating income | $m | [332](/filings/0000849399-25-000006.md) | [397 d](/filings/0000849399-26-000017.md) | [417](/filings/0000849399-25-000059.md) | [402](/filings/0000849399-25-000092.md) | [374](/filings/0000849399-26-000004.md) | [417 d](/filings/0000849399-26-000017.md) | [446](/filings/0000849399-26-000031.md) | [438](/filings/0000849399-26-000083.md) | [433](/filings/0000849399-26-000004.md) | [803 d](/filings/0000849399-26-000017.md) | [443](/filings/0000849399-26-000031.md) | [507](/filings/0000849399-26-000083.md) |
| Income tax | $m | [36.0](/filings/0000849399-25-000006.md) | [81.0 d](/filings/0000849399-26-000017.md) | [95.0](/filings/0000849399-25-000059.md) | [97.0](/filings/0000849399-25-000092.md) | [49.0](/filings/0000849399-26-000004.md) | [145 d](/filings/0000849399-26-000017.md) | [165](/filings/0000849399-26-000031.md) | [99.0](/filings/0000849399-26-000083.md) | [117](/filings/0000849399-26-000004.md) | [157 d](/filings/0000849399-26-000017.md) | [108](/filings/0000849399-26-000031.md) | [99.0](/filings/0000849399-26-000083.md) |
| Net income | $m | [142](/filings/0000849399-25-000006.md) | [131 d](/filings/0000849399-26-000017.md) | [181](/filings/0000849399-25-000059.md) | [161](/filings/0000849399-25-000092.md) | [159](/filings/0000849399-26-000004.md) | [142 d](/filings/0000849399-26-000017.md) | [135](/filings/0000849399-26-000031.md) | [134](/filings/0000849399-26-000083.md) | [192](/filings/0000849399-26-000004.md) | [512 d](/filings/0000849399-26-000017.md) | [215](/filings/0000849399-26-000031.md) | [287](/filings/0000849399-26-000083.md) |
| Diluted EPS | $ per share | [0.22](/filings/0000849399-25-000006.md) | not reported | [0.29](/filings/0000849399-25-000059.md) | [0.26](/filings/0000849399-25-000092.md) | [0.26](/filings/0000849399-26-000004.md) | not reported | [0.22](/filings/0000849399-26-000031.md) | [0.21](/filings/0000849399-26-000083.md) | [0.31](/filings/0000849399-26-000004.md) | not reported | [0.36](/filings/0000849399-26-000031.md) | [0.48](/filings/0000849399-26-000083.md) |
| Basic EPS | $ per share | [0.22](/filings/0000849399-25-000006.md) | not reported | [0.29](/filings/0000849399-25-000059.md) | [0.26](/filings/0000849399-25-000092.md) | [0.26](/filings/0000849399-26-000004.md) | not reported | [0.22](/filings/0000849399-26-000031.md) | [0.22](/filings/0000849399-26-000083.md) | [0.31](/filings/0000849399-26-000004.md) | not reported | [0.36](/filings/0000849399-26-000031.md) | [0.48](/filings/0000849399-26-000083.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-12-29) | FY2024 (2024-03-29) | Q1 FY2025 (2024-06-28) | Q2 FY2025 (2024-09-27) | Q3 FY2025 (2024-12-27) | FY2025 (2025-03-28) | Q1 FY2026 (2025-07-04) | Q2 FY2026 (2025-10-03) | Q3 FY2026 (2026-01-02) | FY2026 (2026-04-03) | Q1 FY2027 (2026-07-03) | Q2 FY2027 (2026-10-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0000849399-24-000008.md) | [0.8](/filings/0000849399-25-000033.md) | [0.6](/filings/0000849399-24-000042.md) | [0.7](/filings/0000849399-24-000081.md) | [0.9](/filings/0000849399-25-000006.md) | [1.0](/filings/0000849399-25-000033.md) | [0.4](/filings/0000849399-25-000059.md) | [0.4](/filings/0000849399-25-000092.md) | [0.3](/filings/0000849399-26-000004.md) | [0.3](/filings/0000849399-26-000083.md) | [0.4](/filings/0000849399-26-000031.md) | [0.4](/filings/0000849399-26-000083.md) |
| Current assets | $bn | [1.7](/filings/0000849399-24-000008.md) | [1.4](/filings/0000849399-25-000033.md) | [1.1](/filings/0000849399-24-000042.md) | [1.2](/filings/0000849399-24-000081.md) | [1.3](/filings/0000849399-25-000006.md) | [1.4](/filings/0000849399-26-000017.md) | [1.4](/filings/0000849399-25-000059.md) | [1.3](/filings/0000849399-25-000092.md) | [1.3](/filings/0000849399-26-000004.md) | [1.1](/filings/0000849399-26-000083.md) | [1.3](/filings/0000849399-26-000031.md) | [1.3](/filings/0000849399-26-000083.md) |
| Total assets | $bn | [16.3](/filings/0000849399-24-000008.md) | [15.8](/filings/0000849399-25-000033.md) | [15.4](/filings/0000849399-24-000042.md) | [15.5](/filings/0000849399-24-000081.md) | [15.4](/filings/0000849399-25-000006.md) | [15.5](/filings/0000849399-26-000017.md) | [16.4](/filings/0000849399-25-000059.md) | [16.1](/filings/0000849399-25-000092.md) | [15.8](/filings/0000849399-26-000004.md) | [15.6](/filings/0000849399-26-000083.md) | [15.6](/filings/0000849399-26-000031.md) | [15.5](/filings/0000849399-26-000083.md) |
| Current liabilities | $bn | [2.6](/filings/0000849399-24-000008.md) | [2.7](/filings/0000849399-25-000033.md) | [3.8](/filings/0000849399-24-000042.md) | [3.8](/filings/0000849399-24-000081.md) | [3.8](/filings/0000849399-25-000006.md) | [2.9](/filings/0000849399-26-000017.md) | [2.9](/filings/0000849399-25-000059.md) | [2.6](/filings/0000849399-25-000092.md) | [2.7](/filings/0000849399-26-000004.md) | [2.7](/filings/0000849399-26-000083.md) | [2.7](/filings/0000849399-26-000031.md) | [3.5](/filings/0000849399-26-000083.md) |
| Total liabilities | $bn | [13.9](/filings/0000849399-24-000008.md) | [13.7](/filings/0000849399-25-000033.md) | [13.5](/filings/0000849399-24-000042.md) | [13.4](/filings/0000849399-24-000081.md) | [13.2](/filings/0000849399-25-000006.md) | [13.2](/filings/0000849399-26-000017.md) | [14.0](/filings/0000849399-25-000059.md) | [13.6](/filings/0000849399-25-000092.md) | [13.5](/filings/0000849399-26-000004.md) | [13.0](/filings/0000849399-26-000083.md) | [13.0](/filings/0000849399-26-000031.md) | [12.8](/filings/0000849399-26-000083.md) |
| Long-term debt | $bn | [9.1](/filings/0000849399-24-000008.md) | [8.4](/filings/0000849399-25-000033.md) | [7.2](/filings/0000849399-24-000042.md) | [7.1](/filings/0000849399-24-000081.md) | [7.1](/filings/0000849399-25-000006.md) | [8.0](/filings/0000849399-26-000017.md) | [8.6](/filings/0000849399-25-000059.md) | [8.4](/filings/0000849399-25-000092.md) | [8.2](/filings/0000849399-26-000004.md) | [8.0](/filings/0000849399-26-000083.md) | [8.0](/filings/0000849399-26-000031.md) | [7.0](/filings/0000849399-26-000083.md) |
| Current portion of debt | $bn | [0.2](/filings/0000849399-24-000008.md) | [0.2](/filings/0000849399-25-000033.md) | [1.3](/filings/0000849399-24-000042.md) | [1.4](/filings/0000849399-24-000081.md) | [1.4](/filings/0000849399-25-000006.md) | [0.3](/filings/0000849399-26-000017.md) | [0.3](/filings/0000849399-25-000059.md) | [0.3](/filings/0000849399-25-000092.md) | [0.2](/filings/0000849399-26-000004.md) | [0.2](/filings/0000849399-26-000083.md) | [0.2](/filings/0000849399-26-000031.md) | [1.1](/filings/0000849399-26-000083.md) |
| Shareholders' equity | $bn | [2.4](/filings/0000849399-25-000006.md) | [2.1](/filings/0000849399-26-000017.md) | [2.0](/filings/0000849399-25-000092.md) | [2.1](/filings/0000849399-26-000004.md) | [2.2](/filings/0000849399-26-000004.md) | [2.3](/filings/0000849399-26-000083.md) | [2.4](/filings/0000849399-26-000083.md) | [2.5](/filings/0000849399-26-000083.md) | [2.3](/filings/0000849399-26-000004.md) | [2.6](/filings/0000849399-26-000083.md) | [2.7](/filings/0000849399-26-000083.md) | [2.7](/filings/0000849399-26-000083.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-12-29) | Q4 FY2024 (2024-03-29) | Q1 FY2025 (2024-06-28) | Q2 FY2025 (2024-09-27) | Q3 FY2025 (2024-12-27) | Q4 FY2025 (2025-03-28) | Q1 FY2026 (2025-07-04) | Q2 FY2026 (2025-10-03) | Q3 FY2026 (2026-01-02) | Q4 FY2026 (2026-04-03) | Q1 FY2027 (2026-07-03) | Q2 FY2027 (2026-10-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [315 d](/filings/0000849399-25-000006.md) | [1,398 d](/filings/0000849399-26-000017.md) | [264](/filings/0000849399-25-000059.md) | [158 d](/filings/0000849399-25-000092.md) | [326 d](/filings/0000849399-26-000004.md) | [473 d](/filings/0000849399-26-000017.md) | [409](/filings/0000849399-26-000031.md) | [116 d](/filings/0000849399-26-000083.md) | [541 d](/filings/0000849399-26-000004.md) | [479 d](/filings/0000849399-26-000017.md) | [434](/filings/0000849399-26-000031.md) | [326 d](/filings/0000849399-26-000083.md) |
| Capital expenditure | $m | [8.0 d](/filings/0000849399-25-000006.md) | [3.0 d](/filings/0000849399-26-000017.md) | [2.0](/filings/0000849399-25-000059.md) | [2.0 d](/filings/0000849399-25-000092.md) | [8.0 d](/filings/0000849399-26-000004.md) | [3.0 d](/filings/0000849399-26-000017.md) | [4.0](/filings/0000849399-26-000031.md) | [9.0 d](/filings/0000849399-26-000083.md) | [6.0 d](/filings/0000849399-26-000004.md) | [3.0 d](/filings/0000849399-26-000017.md) | [4.0](/filings/0000849399-26-000031.md) | [3.0 d](/filings/0000849399-26-000083.md) |
| Dividends paid | $m | [81.0 d](/filings/0000849399-25-000006.md) | [78.0 d](/filings/0000849399-26-000017.md) | [82.0](/filings/0000849399-25-000059.md) | [77.0 d](/filings/0000849399-25-000092.md) | [77.0 d](/filings/0000849399-26-000004.md) | [77.0 d](/filings/0000849399-26-000017.md) | [82.0](/filings/0000849399-26-000031.md) | [77.0 d](/filings/0000849399-26-000083.md) | [77.0 d](/filings/0000849399-26-000004.md) | [76.0 d](/filings/0000849399-26-000017.md) | [81.0](/filings/0000849399-26-000031.md) | [76.0 d](/filings/0000849399-26-000083.md) |
| Share repurchases | $m | [100 d](/filings/0000849399-25-000006.md) | [300 d](/filings/0000849399-26-000017.md) | [272](/filings/0000849399-25-000059.md) | [0.0 d](/filings/0000849399-25-000092.md) | [0.0 d](/filings/0000849399-26-000004.md) | [0.0 d](/filings/0000849399-26-000017.md) | [134](/filings/0000849399-26-000031.md) | [0.0 d](/filings/0000849399-26-000083.md) | [300 d](/filings/0000849399-26-000004.md) | [200 d](/filings/0000849399-26-000017.md) | [100](/filings/0000849399-26-000031.md) | [171 d](/filings/0000849399-26-000083.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-12-30) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-29) | Q3 FY2024 (2023-12-29) | Q1 FY2025 (2024-06-28) | Q2 FY2025 (2024-09-27) | Q3 FY2025 (2024-12-27) | Q1 FY2026 (2025-07-04) | Q2 FY2026 (2025-10-03) | Q3 FY2026 (2026-01-02) | Q1 FY2027 (2026-07-03) | Q2 FY2027 (2026-10-02) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [651](/filings/0000849399-24-000008.md) | [643](/filings/0000849399-24-000042.md) | [644](/filings/0000849399-24-000081.md) | [645](/filings/0000849399-25-000006.md) | [627](/filings/0000849399-25-000059.md) | [622](/filings/0000849399-25-000092.md) | [623](/filings/0000849399-26-000004.md) | [624](/filings/0000849399-26-000031.md) | [624](/filings/0000849399-26-000083.md) | [618](/filings/0000849399-26-000004.md) | [603](/filings/0000849399-26-000031.md) | [603](/filings/0000849399-26-000083.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 593,276,080 at 2026-10-26, from the cover of the [10-Q filed 2026-10-29](/filings/0000849399-26-000083.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 16:57 ET. No prices; not investment advice.